Koninklijke Philips N.V. (ADR)
General ticker "PHG" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $26.7B (TTM average)
Koninklijke Philips N.V. (ADR) does not follow the US Stock Market performance with the rate: -11.5%.
Estimated limits based on current volatility of 1.0%: low 25.26$, high 25.77$
Factors to consider:
- Company pays dividends (annually): last record date 2026-05-13, amount 0.99$ (Y3.85%)
- Total employees count: 65340 (+166.2%) as of 2025
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [24.34$, 37.18$]
- 2026-12-31 to 2027-12-31 estimated range: [26.95$, 40.69$]
Financial Metrics affecting the PHG estimates:
- Positive: with PPE of 15.5 at the end of fiscal year the price was neutral
- Positive: 7.80 < Operating profit margin, % of 7.98
- Positive: 4.90 < Operating cash flow per share per price, % of 5.24
- Positive: 34.41 < Shareholder equity ratio, % of 40.67 <= 42.26
- Positive: Interest expense per share per price, % of 1.50 <= 2.54
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 3.23
- Positive: -4.49 < Investing cash flow per share per price, % of -3.32
Short-term PHG quotes
Long-term PHG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €18,169.00MM | €18,021.00MM | €17,834.00MM |
| Operating Expenses | €18,284.00MM | €17,492.00MM | €16,410.00MM |
| Operating Income | €-115.00MM | €529.00MM | €1,424.00MM |
| Non-Operating Income | €-412.00MM | €-406.00MM | €-242.00MM |
| Interest Expense | €306.00MM | €337.00MM | €332.34MM |
| R&D Expense | €1,890.00MM | €1,747.00MM | €1,700.00MM |
| Income(Loss) | €-527.00MM | €123.00MM | €1,182.00MM |
| Taxes | €-73.00MM | €963.00MM | €282.00MM |
| Net Income(Loss)* | €-466.00MM | €-702.00MM | €895.00MM |
| Stockholders Equity | €12,028.00MM | €12,006.00MM | €10,957.00MM |
| Inventory | €3,491.00MM | €3,198.00MM | €2,870.00MM |
| Assets | €29,406.00MM | €28,976.00MM | €26,944.00MM |
| Operating Cash Flow | €2,309.26MM | €1,697.17MM | €1,162.00MM |
| Capital expenditure | €371.90MM | €342.90MM | €269.00MM |
| Investing Cash Flow | €-553.53MM | €-633.87MM | €-737.00MM |
| Financing Cash Flow | €-916.79MM | €-536.52MM | €107.00MM |
| Earnings Per Share** | €-0.49 | €-0.75 | €0.93 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.